Rapid Voltammetric Identification and Determination of Simvastatin at Trace Levels in Pharmaceuticals and Biological Fluid by Nigović, Biljana et al.
Rapid Voltammetric Identification and Determination of Simvastatin
at Trace Levels in Pharmaceuticals and Biological Fluid
Biljana Nigovi},a,* [ebojka Komorsky-Lovri},b and Dubravka Dev~i}a
a
Faculty of Pharmacy and Biochemistry, University of Zagreb, HR-10000 Zagreb, Croatia
b
Center for Marine and Environmental Research, Ru|er Bo{kovi} Institute, P.O. Box 180, HR-10002 Zagreb, Croatia
RECEIVED JANUARY 8, 2007; REVISED MAY 21, 2007; ACCEPTED JUNE 20, 2007
Simvastatin is used as an antilipemic agent through inhibition of 3-hydroxy-3-methylglutaryl-
coenzyme A reductase. The reduction behavior of drug has been studied in different supporting
electrolytes within the pH range 3–9. Based on the adsorptive character of simvastatin onto the
mercury electrode surface, a new cathodic square-wave stripping voltammetry method for its
direct determination at trace levels has been proposed. The voltammetric response could be
used to determine drug concentration in the range 1.0 × 10–8 to 7.5 × 10–7 mol L–1, with detec-
tion limit of 4.5 × 10–9 mol L–1. Applicability to biological fluid analysis was illustrated. The
method was successfully employed, without sample pretreatment, for quantitation of the active
ingredient simvastatin in pharmaceuticals. The use of abrasive stripping voltammetry for rapid
identification of this drug in pharmaceutical dosage forms using a paraffin-impregnated graph-
ite electrode has been examined.
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INTRODUCTION
Simvastatin belongs to a class of drugs called statins,
which act by inhibition of 3-hydroxy-3-methylglutaryl-
coenzyme A reductase. This microsomal enzyme cata-
lyzes the rate-limiting step of cholesterol biosynthesis.
Also, simvastatin inhibits oxidation of native and modi-
fied low-density and high-density lipoproteins.1 Statins
are currently the most therapeutically effective drugs avail-
able for reducing LDL cholesterol and triglyceride levels
in the blood stream of patients at risk of cardiovascular
disease,2 even they are now among the most frequently
prescribed drugs.3
The chemical structure of simvastatin contains a b-
hydroxy-lactone (Scheme 1). The physiologically active
form of the drug is the b-hydroxy acid, which is formed
by a ring-opening reaction of the lactone ring. In vivo,
prodrug lactone form is enzymatically hydrolysed to its
hydroxyl-acid pharmacophore.4
Developments of sensitive and selective analytical
methods to the determination of drugs are highly requir-
ed. Simvastatin has been determined in pharmaceutical
preparations and biological fluids using several methods
including, high-performance liquid chromatography com-
bined with mass spectrometry,5–8 fluorescence9 or UV de-
tection,10 gas chromatography,11 capillary electropho-
resis12 and UV spectroscopy.13 However, some of these
methods require expensive equipment and are time-con-
suming. In some cases, the methods entail an extraction
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and derivatization procedures due to their relatively low
sensitivities. Hence, a more rapid and simpler method for
identification and determination of simvastatin at trace
levels is highly desirable.
In a previous paper14 we have been described the re-
sults of preliminary investigation of electrochemical pro-
perties of solid and dissolved simvastatin using cyclic and
square-wave voltammetry. During the preparation of this
manuscript, a paper dealing with the electrochemical de-
termination of simvastatin appeared, but it is based on
oxidation of drug at glassy carbon electrode.15 Up to date
no attempt has been made to study the adsorptive strip-
ping voltammetric behaviour of simvastatin. In this work
we extend our investigations to the development of a
sensitive voltammetric method for the direct determina-
tion of this compound in bulk form, pharmaceutical for-
mulation and human serum based on the reduction of
simvastatin at a hanging mercury-drop electrode. A qua-
litative analysis of powders of pharmaceutical dosage
forms using the abrasive stripping voltammetry has been
performed.
EXPERIMENTAL
Materials and Reagents
Simvastatin, kindly supplied by Pliva (Zagreb, Croatia),
was used without any purification. Stock solution (1 × 10–3
mol L–1) was prepared in acetonitrile and stored at 4 °C in a
refrigerator. Simvastatin and its acid form showed 1 % in-
terconversion at 4 °C after 4 weeks.6 Standard solutions
were prepared daily by diluting the stock solution with a se-
lected supporting electrolyte just before use.
The supporting electrolytes solutions, Britton-Robinson
buffer (0.04 mol L–1 in each of acetic, phosphoric and boric
acids) adjusted to the desired pH of 3–9 with 0.2 mol L–1
sodium hydroxide solution, 0.1 mol L–1 Na2B4O7-KH2PO4
buffer (pH = 5–8) and McIlvain buffer (0.1 mol L–1 citric acid
and 0.2 mol L–1 Na2HPO4; pH = 6–8) were used for square-
wave voltammetry on the hanging mercury-drop electrode.
The supporting electrolyte for abrasive stripping voltamme-
tric measurements was prepared by adding 1 mL of 0.1 mol
L–1 buffer solution and 0.1 mL of 0.1 % Triton-X-100 solu-
tion to 9 mL of 0.1 mol L–1 NaClO4 solution. All the chemi-
cals used were of analytical reagent grade quality (Aldrich
or Kemika). Purified water from a Millipore Milli-Q sys-
tem was used throughout the study.
Apparatus
A potentiostat Model 273 A and the SMDE in hanging mer-
cury-drop electrode Model 303 A (both Princeton Applied
Research) were used in the cyclic and square-wave
voltammetry. The active area of the working mercury drop
electrode was 0.026 cm2. The Ag/AgCl (saturated KCl)
served as a reference electrode and a platinum wire was
used as a counter electrode. A magnetic stirrer (PAR Model
305) provided the convective mass transport during the ac-
cumulation step.
Abrasive stripping voltammetric measurements were
performed by using a multimode polarograph Autolab 30
(EcoChemie, Utrecht). The working electrode was a spec-
tral-grade paraffin-impregnated graphite rod (diameter 5 mm,
length 50 mm). Its clean and carefully polished circular sur-
face was contaminated with microparticles of simvastatin
by pressing it into a small pile of substance powder on a
highly glazed ceramic tile and moving it with a circular
motion for about 10 s. Less than 1 mm of the graphite rod
was immersed in the electrolyte only during the voltamme-
tric measurements. The Pt wire was on auxiliary electrode
and Ag/AgCl/3 mol L–1 KCl (Metrohm) was a reference
electrode.
The pH measurements were made with a Radiometer
PHM 85 pH-Meter using combined glass electrode (Radio-
meter PHC 2406L).
Procedure
Supporting electrolyte (10 mL) was placed in the electro-
analytical cell and the required aliquot of standard simva-
statin solution was added by a micropipette. The solution
was deoxygenated prior to analysis by purging with puri-
fied nitrogen for 8 min with the stirrer on. The samples
were blanketed with nitrogen during acquisition. After form-
ing a new mercury drop, the square-wave voltamogram was
recorded either immediately in quiescent solution or after
adsorptive accumulation for a selected time at the predeter-
454 B. NIGOVI] et al.
Croat. Chem. Acta 81 (3) 453¿459 (2008)
CH3
H3C
O
O
CH3
H3C
O
HO O
CH3
H3C
O
O
CH3
H3C
OH
HO
OH
O
H3CH3C
1 2
Scheme 1. Molecular structures of simvastatin (1) and physiologically active simvastatin b-hydroxy acid form (2).
mined potential in stirred solution. A quiescent period of 15 s
was allowed before commencing the potential scan. All mea-
surements were carried out at the room temperature.
Analysis of Pharmaceutical Dosage Form
Statex® film-tablets, each containing 20 mg of simvastatin,
were obtained from the commercial sources (Pliva). Excipi-
ents, such as lactose, microcrystalline cellulose, hydroxypro-
pyl-methylcellulose, iron oxide and titanium dioxide, are ad-
ded to dosage forms. Twenty tablets were weighed and pow-
dered. A portion of powder equivalent to the average mass of
one tablet was transferred into a 50 mL calibrated flask and
25 mL of acetonitril was added to dissolve the active mate-
rial. After sonicating and shaking the mixture for 5 min, it
was completed to volume with the same solvent, mixed and
passed through a 0.5 mm mash filter. An aliquot of the fil-
trate was then transferred into a calibrated flask and a series
of dilutions was made with 0.1 mol L–1 Na2B4O7-KH2PO4
buffer at pH = 7 as supporting electrolyte, covering the
working concentration range (1.0 × 10–6 to 1.0 × 10–5 mol
L–1). Solutions of the compound studied were subjected to
voltammetric measurements as previously mentioned. For re-
covery experiments, known amounts of pure drug were
added to the different preanalyzed samples of a commercial
formulation and the mixtures were analysed by the proposed
method. This step was repeated three times for determination
of simvastatin by the standard addition technique.
For qualitative analysis, the surface of paraffin-impreg-
nated graphite electrode was contaminated with micro-
particles of powders of simvastatin film-tablets. The volta-
mograms were recorded according to the above recom-
mended procedure for simvastatin using abrasive stripping
voltammetry.
Recovery Studies in Spiked Human Serum Samples
Serum samples were obtained from healthy volunteers and
stored frozen until assay. A 500 µL aliquot of human serum
samples was mixed with acetonitrile (1.5 mL) and with ap-
propriate aliquot volume of simvastatin stock solution in
centrifuge tube. The mixture was vortex for 5 min. After
deproteination and centrifugation of the sample for 10 min
at 6000 rpm the supernatant was separated. Appropriate vo-
lumes of clear supernatant solution were analysed in the vol-
tammetric cell containing 0.1 mol L–1 Na2B4O7-KH2PO4
buffer, pH = 7. A blank was prepared under the same condi-
tions but without simvastatin. Measurements were obtained
in the square-wave mode under the following optimized con-
ditions: accumulation potential Eacc = –0.8 V; accumulation
time tacc = 60 s; frequency f = 500 Hz; pulse amplitude ESW =
40 mV and scan increment Es.inc. = 2 mV.
RESULTS AND DISCUSSION
Voltammetric Behaviour of Simvastatin
The electrochemical reduction of simvastatin at the hang-
ing mercury-drop electrode was studied by means of cy-
clic and square-wave voltammetry in different support-
ing electrolytes over a wide pH range (3–9) in Britton-
Robinson, 0.1 mol L–1 Na2B4O7-KH2PO4 and McIlvain
buffers (Figure 1). Cyclic and square-wave voltamograms
exhibited two peaks over the pH range 4–8. Cyclic vol-
tammetric measurements show the reversible nature of the
first reduction wave in the whole pH range investigated,
while the second one is irreversible in the range of the
scan rates between 100–5000 mV s–1. Square-wave
voltamograms of the drug contain a pair of well-defined
cathodic and anodic peaks for both electrode reaction at
the frequencies higher then 100 Hz. The forward and
backward components of the responses indicate that the
redox reactions are reversible below pH = 8.5. Such vol-
tammetric behaviour, in agreement with our previous
findings,14 implies that the electroreduction of simvasta-
tin proceeds via a surface EC mechanism in the whole
pH range investigated.
The net peak potential of the reduction process was
pH independent between pH = 3 and pH = 9 (slope of
IDENTIFICATION AND DETERMINATION OF SIMVASTATIN 455
Croat. Chem. Acta 81 (3) 453¿459 (2008)
i
/µA
E /V
-0.4 -0.6 -0.8 -1.0 -1.2 -1.4 -1.6 -1.8
0
20
40
60
80
1
2
3
4
5
Figure 1. Influence of supporting electrolyte on simvastatin reduc-
tion: Britton-Robinson buffer pH = 3 (1), pH = 5 (2), pH = 9 (3);
Na2B4O7-KH2PO4 buffer pH = 7 (4) and McIlvain buffer pH = 6
(5). Conditions: c = 1 × 10–5 mol L–1, ESW = 50 mV, f = 400 Hz.
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Figure 2. Dependence of peak potentials on simvastatin concentra-
tion at hanging mercury-drop electrode in 0.1 mol L–1 Na2B4O7-
KH2PO4 buffer, pH = 7; c = 1 × 10–4 (1), 1 × 10–5 (2) and
1 × 10–6 mol L–1 (3).
7.7 mV/pH) indicating that the protons are involved af-
ter the rate determination step, followed by the chemical
reaction yielding the final product. Net square-wave vol-
tammetric response of simvastatin is shifted towards
more negative values by increasing the concentration of
analytes (Figure 2) such as observed in the electroreduc-
tion of pravastatin.16 The linear relationship between the
peak potentials and the logarithm of simvastatin concen-
tration with the slope of DEp / Dlogc = – 41 mV indica-
tes also that the reduction of the drug is followed by a
chemical reaction. Pravastatin is administered to patients
in its active hydroxyl acid form and the voltammetric re-
sponse of pravastatin is related to reduction of its ester
group in the side chain. However, simvastatin is lactone
which can be converted to the corresponding hydroxyl
acid form in alkaline condition. The effect of pH values
in the pH range 3–9 on the reduction peak of simvastatin
showed that the peak current increased gradually upon
increasing the pH values from 3 to 6, and than remained
nearly unchanged from 6.5 to 8. However, a sharp de-
crease in the current response upon increasing the pH
values from 8 to 9 was observed. On the other hand,
within the pH range 5–8 the peak current decays over
time. Sample solution recorded after 24 h showed appre-
ciable change in cathodic peak current. Simvastatin is in
the prodrug lactone form in the solution used. Intercon-
version of b-hydroxy-lactone to the b-hydroxy acid is
pH-dependent. The dependence of the voltammetric re-
sponse on the pH values indicates that the degree of
ring-opening increased with the pH values increasing
from 8 to 9 to result in the peak current decrease. Sam-
ples stored in refrigerator for up to 24 h showed decreas-
ing concentration of simvastatin lactone form over time,
pointing to the hydrolysis of lactone to b-hydroxy acid
form in aqueous media. Therefore, it could be concluded
that the reduction of simvastatin on the mercury electro-
de occurred at the carbonyl group on the lactone ring.
The first peak current was considered for the present
analytical investigations owing to its high signal relative
to that of the second one. Considering both the reduction
current and the peak shape, 0.1 mol L–1 Na2B4O7-KH2PO4
buffer pH = 7 was chosen in all subsequent analytical
studies.
A corresponding analysis in square-wave voltam-
metry was undertaken by varying the frequency and am-
plitude of the signal. To obtain a much more sensitive
peak current for analytical studies, the square-wave fre-
quency and amplitude were changed between 50 and
900 Hz, and from 10 to 120 mV, respectively. At the fre-
quencies lower than 300 Hz, the first response splits into
two peaks (Figure 3). The separation of the peaks of the
split response is proportional to the square-wave ampli-
tude. The response of this type of reaction is the highest
when the charge transfer rate is synchronized with the
frequency of the square-wave signal. The sensitivity of
the electroanalytical technique depends primarily on the
kinetics of the redox reaction. As regards the change of
capacitive currents, the best signal-to-noise ratio was ob-
tained with the frequency of 500 Hz which was selected
for analytical application. The best peak definition was
recorded when using 40 mV pulse amplitude and 2 mV
scan increment.
Application to the Trace Analysis
Electroanalytical procedures based on simvastatin reduc-
tion were developed, involving square-wave and adsorp-
tive stripping square-wave voltammetry for quantitative
determination of the drug at low levels. Since the reduc-
tion of simvastatin on mercury electrode is a surface re-
dox reaction,14 spontaneous adsorption of drug can be
used as an effective preconcentration step before voltam-
metric measurement (Figure 4). It is necessary to select
the variable affecting the adsorptive process. Different
square-wave voltamograms with increasing accumulation
times (between 0 s and 90 s) were recorded for solutions
containing simvastatin at various concentration levels
(5 × 10–7 and 1 × 10–7 mol L–1). The peak current increas-
ed up to a maximum at 90 s and then remained constant
suggesting saturation of the surface coverage of adsorb-
ed simvastatin. The value of 60 s was found as the opti-
456 B. NIGOVI] et al.
Croat. Chem. Acta 81 (3) 453¿459 (2008)
-0.4 -0.6 -0.8 -1.0 -1.2 -1.4 -1.6 -1.8
-5
0
5
10
I
f
(a)
I
net
I
b
-0.4 -0.6 -0.8 -1.0 -1.2 -1.4 -1.6 -1.8
-40
0
40
80
120
I
b
I
f
I
net
(b)
i
/µA
E /V
i
/µA
E /V
Figure 3. The effect of the square-wave frequency on the shape of
the voltammetric response of 1 × 10–5 mol L–1 simvastatin solu-
tions; frequencies are 100 Hz (a) and 400 Hz (b), ESW = 50 mV.
Net response (Inet) and its forward (If) and backward (Ib) com-
ponents.
mum accumulation time because it provided the largest
peak current in the linearity range. The influence of ac-
cumulation potential on the stripping peak current was
evaluated from –0.2 to –1.0 V. A maximum was observ-
ed at –0.8 V, so this deposition potential was selected in
all subsequent studies.
When all parameters that can affect simvastatin quan-
tification had been studied, variation of the peak current
with the bulk drug concentration was performed. In the
case of a square-wave scan without any accumulation
step, the reduction peak was linearly proportional to
simvastatin concentration in the range of 1 × 10–6 to 1 ×
10–5 mol L–1. By using drug accumulation at the hanging
mercury-drop electrode prior to square-wave voltammetric
measurement, higher sensitivities can be readily achiev-
ed. The relation between the stripping peak current and
concentration was found to be linear over the range
1 × 10–8 to 7.5 × 10–7 mol L–1. The analytical charac-
teristics and the related validation parameters of both
methods are given in Table I. The limits of detection and
quantification of both procedures were calculated from
the calibration curves as 3 s / m and 10 s / m, respec-
tively, where s is the standard deviation of the intercept
and m is the slope of the calibration curve.17 These val-
ues confirmed the sensitivity of the proposed methods for
drug determination.
In this study, square-wave voltammetry was propos-
ed as an alternative method for drug quantitation, since
applying the wave form allowed very rapid determina-
tion. The quantification limit is of the same order as for
some chromatographic methods reported previously8 and
is better than for capillary electrophoresis,12 UV spectro-
photometry13 and HPLC with UV detection10 that is offi-
cial method in assay procedures of simvastatin listed in
European Pharmacopoeia18 and its pharmaceutical prod-
uct described in USP.19 The detection limit is approxi-
mately two orders of magnitude better than the value re-
ported for voltammetry based on the electrooxidation of
the drug.15
The precision was evaluated by repeating seven inde-
pendent measurements of 5 × 10–7 and 1 × 10–6 mol L–1
simvastatin solutions. Relative standard deviation ranged
from 0.8 to 1.6 %. To evaluate the repeatability and re-
producibility of the electrode response, analysis of stan-
dard simvastatin at three concentration levels of the cali-
bration curve was tested by performing five experiments
on the same day using the same analyte standard so-
lution and over four consecutive days using different
standard solutions. Mean recoveries of (99.5 ± 0.7) and
(99.0 ± 1.2) %, square-wave, (98.4 ± 0.9) and (98.2 ± 1.4) %,
adsorptive stripping square-wave voltammetry, were achie-
ved by intra-day and inter-day determinations of sim-
vastatin, respectively. The recovery results obtained in-
dicate both the good precision of the proposed procedu-
res and the stability of the solutions for the study period.
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Figure 4. Square-wave voltamograms of simvastatin at hanging
mercury-drop electrode after preconcentration time of 60 s (1) and
without preconcentration (2). Conditions: c = 7.5 × 10–7 mol L–1,
Eacc = –0.8 V, ESW = 40 mV, f = 500 Hz.
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Figure 5. Stripping square-wave voltamograms in human serum
samples: background (1) and different concentration of simvastatin
over the range 5 × 10–8 to 7.5 × 10–7 mol L–1 (2–8). Accumulation
time, 60 s; other conditions are the same as in Figure 4.
TABLE I. Analytical parameters of the calibration graph in the
simvastatin determination by square-wave and adsorptive strip-
ping square-wave voltammetry
Parameter SWV AdSWV
Linearity range / mol L–1 1.0 × 10–6 to
1.0 × 10–5
1.0 × 10–8 to
7.5 × 10–7
Slope of calibration
plot / mA mol–1 L
1.33 × 107 2.94 × 107
Intercept / mA 1.076 0.786
Correlation coefficient 0.999 0.999
Sy/x 1.955 0.079
Sa 0.279 0.119
Sb 1.549 0.045
Limit of detection / mol L–1 3.5 × 10–7 4.5 × 10–9
Limit of quantitation / mol L–1 1.1 × 10–6 1.5 × 10–8
To check the applicability of the proposed method, a
commercial film-tablet containing simvastatin was ana-
lyzed. Due to the high concentration of active ingredient
in its dosage form (20 mg of simvastatin per tablet), the
tablets assay was carried out directly by means of cathodic
square-wave voltammetric technique. The simvastatin con-
tent in commercially available tablets was determined by
estimating the recoveries at five different concentration
levels using the corresponding calibration equation. Ap-
plication of the square-wave voltammetric method to the
determination of active ingredient in a pharmaceutical
formulation, after a simple dilution step, resulted in ac-
ceptable deviation from the stated concentration. Recov-
eries of the drug from this type of matrix ranged from
98.2 to 99.9 % with relative standard deviations ranging
from 1.6 to 2.5 %. To determine whether the excipients
used in the dosage forms interfered with the current peak
of interest, recovery experiments were carried out by the
standard addition method. Each recovery was calculated
by comparing the results obtained before and after addi-
tion. The mean concentration obtained was 19.85 mg per
tablet with the relative standard deviation of 1.8 %, indi-
cating adequate accuracy and precision of the proposed
analysis procedures. Comparison of simvastatin recover-
ies obtained using the calibration curve and the standard
addition method revealed that excipients did not inter-
fere with the analysis. Moreover, the slope ratio between
the slope of the standard calibration graph and the slope
of the line obtained by standard additions of known
quantities of pure drug to the pre-analyzed solution of
formulations, and multiplied by 100, was 100.6 %. New
developed method can therefore be used as a selective
method that is very precise, rapid and inexpensive. The
proposed voltammetric method might be applied as an
alternative to more used HPLC or UV spectroscopic tech-
nique for formulation screening, release and dissolution
testing of simvastatin in the solid dosage form.
The possibility of applying adsorptive stripping square-
wave voltammetric procedures for the trace analysis of
simvastatin in biological fluid was also tested (Figure 5).
For determination of simvastatin in spiked serum sam-
ples three replicate samples containing three different
levels of drug were processed. The mean recovery of
97.9±1.0 was achieved from this type of matrix. The
proposed adsorptive stripping voltammetry is simpler, fas-
ter and required less expensive equipment than the known
methods for simvastatin analysis in biological fluids and
can be applied to the direct determination of drug in hu-
man serum samples. Using the proposed procedures, no
sample pre-treatment was required, other than precipita-
tion of the serum proteins with acetonitrile and a dilution
step with the selected supporting electrolyte. The peak
current of the first peak considered for the analytical
purposes has been ascribed to reduction of carbonyl group
on lactone ring of simvastatin prodrug. The degree of
hydrolysis of lactone prodrug increased with the pH val-
ues increasing to result in the peak current decrease
(Figure 6). Therefore, the voltammetric procedure shows
the possibility of monitoring the interconversion of sim-
vastatin to physiologically active simvastatin b-hydroxy
acid form.
Electrooxidation of immobilized crystals of simva-
statin at paraffin-impregnated graphite electrode has been
discussed in our previous work.14 Solid microparticles of
the drug, mechanically immobilized on the surface of the
paraffin impregnated graphite electrode, were oxidized in
totally irreversible electrode reaction involving the b-hy-
droxyl group in lactone ring which is also an active site
in the enzymatic b-oxidation of simvastatin.20 Method for
a quick detection of simvastatin has been developed using
the abrasive stripping voltammetry. The voltammetric
response of simvastatin was used for its rapid identifica-
tion in pharmaceuticals (Figure 7). Net peak potential of
the square-wave response of drug in bulk form is 1.107
V. The peak potential of simvastatin microparticles in
film-tablet is 1.119 V. A qualitative analysis of powders
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Figure 6. Stability profile of simvastatin prodrug lactone form as
measured by square-wave voltammetry at different pH values of
Na2B4O7-KH2PO4 buffer. Conditions: c = 4 × 10–6 mol L–1, ESW
= 40 mV, f = 500 Hz.
i
/
m
A
E /V
0.4 0.6 0.8 1.0 1.2 1.4
-0.05
0.00
0.05
0.10
0.15
0.20
0.25
I
f
I
b
I
net
Figure 7. Square-wave voltammetric detection of simvastatin in phar-
maceutical formulation on paraffin-impregnated graphite electrode.
Frequency is 150 Hz, amplitude is 50 mV.
of pharmaceutical dosage forms revealed that the exci-
pients present in tablet do not interfere with simvastatin
detection.
CONCLUSIONS
A square-wave voltammetric procedure of sufficient sen-
sitivity has been established and successfully applied to
direct determination of the drug in a pharmaceutical for-
mulation without interference from excipients. Rapid
identification of active ingredient in dosage form using
abrasive stripping voltammetry has been developed.
Also, the adsorption process of simvastatin occurring on
the mercury electrode surface can be used as an effective
preconcentration step for drug determination at the trace
level in human serum samples. Moreover, the voltamme-
tric procedure could be applied for monitoring the inter-
conversion of simvastatin to physiologically active sim-
vastatin b-hydroxy acid form because the cathodic peak
current considered for the analytical purposes has been
ascribed to reduction of carbonyl group in lactone ring
of simvastatin prodrug.
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Brza identifikacija i odre|ivanje tragova simvastatina u farmaceuticima i biolo{koj teku}ini
Biljana Nigovi}, [ebojka Komorsky-Lovri} i Dubravka Dev~i}
Simvastatin je antihiperlipemik koji inhibira enzim 3-hidroksi-3-metilglutaril-koenzim A reduktazu. Istra-
`ivana je redukcija lijeka u razli~itim elektrolitima u rasponu pH 3–9. Na temelju adsorptivnog pona{anja na
povr{ini `ivine elektrode predlo`ena je metoda za izravno odre|ivanje tragova simvastatina kori{tenjem katodne
pravokutnovalne voltametrije s adsorptivnom akumulacijom. Voltametrijski odaziv je linearna funkcija koncen-
tracija lijeka u rasponu od 1,0 × 10–8 do 7,5 × 10–7 mol L–1, s granicom detekcije od 4,5 × 10–9 mol L–1.
Opisana je primjena metode za odre|ivanje lijeka u biolo{koj teku}ini. Metoda je uspje{no kori{tena za odre|i-
vanje aktivne tvari u farmaceuticima bez prethodne obrade uzorka. Ispitana je primjena abrazivne voltametrije
za brzu potvrdu identiteta lijeka u farmaceutskim dozirnim oblicima uporabom parafinom impregnirane gra-
fitne elektrode.
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